UPDATE: Goldman Sachs Starts Amneal Pharmaceuticals (AMRX) at Sell
Tweet Send to a Friend
(Updated - July 27, 2020 4:50 AM EDT)
(updating comment)Goldman Sachs analyst Nathan Rich initiates coverage on Amneal Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Goldman Sachs analyst Nathan Rich initiates coverage on Amneal Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
